Group 1 - Tianyi Medical has obtained EU MDR certification for its products, including extracorporeal circulation blood lines, feeding syringes, ENFit connector feeding syringes, and arteriovenous puncture devices, indicating compliance with the latest EU medical device regulations and allowing continued legal sales in relevant overseas markets [1] - Chuangyuan Co. has appointed Ye Jinsheng as the new president of the company [2] - Shanghai Laishi has received approval for clinical trials of "SR604 injection" for the prevention and treatment of bleeding episodes in patients with vascular hemophilia [3] - Yingli Co. has had its application for the acquisition of 77.94% of Shenzhen Youteli Energy Co., Ltd. through share issuance and cash payment accepted by the Shenzhen Stock Exchange [4]

Group 1 - Tianyi Medical has obtained EU MDR certification for its products, including extracorporeal circulation blood lines, feeding syringes, feeding syringes with ENFit connectors, and arteriovenous puncture devices, indicating compliance with the latest EU medical device regulations and allowing continued legal sales in relevant overseas markets [1] - Chuangyuan Co. has appointed Ye Jinsheng as the new president of the company [2] - Shanghai Laishi has received approval for clinical trials of "SR604 injection" for the prevention and treatment of bleeding episodes in patients with vascular hemophilia [3] - Yingli Co. has had its application for the acquisition of 77.94% of Shenzhen Youteli Energy Co., Ltd. through share issuance and cash payment, along with the fundraising plan, accepted by the Shenzhen Stock Exchange [4]